Alnylam Pharmaceuticals, Inc.

CAPTRUST FINANCIAL ADVISORS ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

13,255

Value ($000)

5,271

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	5,271	0.0%	13,255	12/31/2025
2025 Q3	11/19/2025	3,497	0.0%	7,669	9/30/2025
2025 Q2	8/15/2025	1,143	0.0%	3,506	6/30/2025
2025 Q1	5/15/2025	1,723	0.0%	6,381	3/31/2025
2024 Q4	2/14/2025	1,509	0.0%	6,414	12/31/2024
2024 Q3	11/14/2024	1,329	0.0%	4,833	9/30/2024
2024 Q2	8/15/2024	874	0.0%	3,596	6/30/2024
2024 Q1	5/15/2024	544	0.0%	3,639	3/31/2024
2023 Q4	2/14/2024	883	0.0%	4,614	12/31/2023
2023 Q3	11/15/2023	742	0.0%	4,187	9/30/2023
2023 Q2	8/15/2023	935	0.0%	4,921	6/30/2023
2023 Q1	5/15/2023	438	0.0%	2,185	3/31/2023
2022 Q4	2/15/2023	384	0.0%	1,615	12/31/2022
2022 Q3	11/16/2022	295	0.0%	1,475	9/30/2022
2022 Q2	8/23/2022	187	0.0%	1,285	6/30/2022
2022 Q1	5/16/2022	201	0.0%	1,232	3/31/2022
2021 Q4	2/14/2022	153	0.0%	903	12/31/2021
2021 Q3	11/16/2021	161	0.0%	853	9/30/2021
2021 Q2	8/16/2021	119	0.0%	702	6/30/2021
2021 Q1	5/17/2021	94	0.0%	666	3/31/2021
2020 Q4	2/16/2021	21	0.0%	163	12/31/2020
2020 Q3	11/17/2020	32	0.0%	223	9/30/2020
2020 Q2	8/14/2020	33	0.0%	223	6/30/2020